He Shengqin,Xiong Jianqiong,Qu Jifu,Zhang Lei,Wang Tao,Zhang Yonghui,Zhang Yan,Chen Kun.Influence of blood purification on serum cytokine levels and prognosis in patients with septic shock[J].J Amry Med Univ (J Third Mil Med Univ),2011,33(10):1061-1064.
He Shengqin,Xiong Jianqiong,Qu Jifu,Zhang Lei,Wang Tao,Zhang Yonghui,Zhang Yan,Chen Kun.Influence of blood purification on serum cytokine levels and prognosis in patients with septic shock[J].J Amry Med Univ (J Third Mil Med Univ),2011,33(10):1061-1064.DOI:
Influence of blood purification on serum cytokine levels and prognosis in patients with septic shock
HP)+连续性静脉-静脉血液滤过组(HP+CVVH),每组12例,分别进行常规治疗、常规治疗+CVVH治疗、常规治疗+HP+CVVH治疗。检测各组治疗后不同时相点血清TNF-α、IL-6、IL-10、HMGB-1浓度,并比较各组1~7 d全身性感染相关性器官功能衰竭评价(sepsis related organ failure assessment,SOFA)评分及28 d存活率的差别。 结果 对照组及CVVH组TNF-α、IL-6、HMGB-1、IL-10在第1、3天各时相点浓度变化均无统计学意义(P0.05);HP+CVVH组中HP治疗2 h后的TNF-α、HMGB-1、IL-10均有明显下降,IL-6也有一定下降,其他时相点浓度变化均无统计学意义(P0.05)。与对照组相比,CVVH组从第4天起SOFA评分即明显降低(P0.05),HP+CVVH组第2天起SOFA评分即明显降低(P0.05);28 d存活率提高(对照组、CVVH组、HP+CVVH组分别为41.67%、58.33%、66.67%),且以HP+CVVH组更明显,但3组间无统计学意义。 结论 CVVH对脓毒性休克患者血清TNF-α、IL-6、HMGB-1、IL-10的水平无明显影响,HP能显著降低血清TNF-α、HMGB-1、IL-10浓度; CVVH及HP+CVVH治疗均能促进脓毒性休克患者器官功能恢复,且以HP+CVVH治疗效果更佳。
Abstract
Objective To investigate the influence of different blood purification methods on serum cytokine levels and prognosis in patients with septic shock
and to study the therapeutic effects of different blood purification methods on the patients. Methods Thirty-six septic shock patients with acute physiology and chronic health evaluation II (APACHEII) scores not smaller than 15 were randomly divided into a control group (C group)
a continuous veno-venous hemofiltration group (CVVH group)
and a hemoperfusion and continuous veno-venous hemofiltration group (HP+CVVH group). The C group underwent conventional therapy. The CVVH group underwent conventional therapy and CVVH therapy. The HP+CVVH group underwent conventional therapy
HP therapy
and CVVH therapy. The levels of serum cytokines including tumor necrosis factor-α (TNF-α)
interleukin-6 (IL-6)
interleukin-10 (IL-10)
and high-mobility group box chromosomal protein-1 (HMGB-1) in each group were measured at different time points after treatment. The survival rates for 28 d and sepsis related organ failure assessment (SOFA) scores at 1 to 7 d of the three groups were compared. Results There was no significant change in the levels of serum TNF-α
IL-6
IL-10
and HMGB-1 at different time points in the first day and the third day in the C group and CVVH group (P0.05). The levels of TNF-α
IL-10
and HMGB-1 significantly decreased 2 h after HP treatment in the HP+CVVH group
and the IL-6 level also decreased. There was no significant difference in the levels of TNF-α
IL-6
IL-10
and HMGB-1 at other times in the HP + CVVH group (P0.05). Compared with the C group
SOFA score started to significantly decrease on the fourth day in the CVVH group (P0.05) and on the second day in the HP+CVVH group (P0.05). The survival rates for 28 d increased in the three groups (41.67% vs 58.33% vs 66.67%)
especially in the HP+CVVH group
without statistical significance among the three groups. Conclusion There is no significant influence of CVVH on the levels of serum TNF-α
IL-6
IL-10
and HMGB-1. HP significantly lowers the levels of serum TNF-α
IL-10
and HMGB-1. Both CVVH therapy and HP+CVVH therapy
especially HP+CVVH therapy
can promote the functional rehabilitation of organs in patients with septic shock.
A novel estrogen receptor expression stratification (low/moderate/high) based on Chinese population provides more accurate prognosis prediction for HR+/HER2- early breast cancer patients
Immunosuppressive microenvironment of TGIF1-overexpressing gastric cancers and its clinical significance
Impact of molecular heterogeneity of NPM1 mutations on prognosis of acute myeloid leukemia: a clinical report of 86 cases
Association of 5-factor modified frailty index and controlling nutritional status score with overall survival in patients with unresectable hepatocellular carcinoma undergoing interventional therapy
Construction and validation of prediction model for cervical cancer recurrence based on systemic inflammation response index and clinicopathological parameters
Related Author
WANG Chengfang
ZHOU Yuqin
ZHANG Yanling
QI Xiaowei
ZHANG Yi
TONG Huyun
CHEN Xu
ZHANG Wenjie
Related Institution
Department of Breast and Thyroid Surgery, First Affiliated Hospital, Army Medical University (Third Military Medical University)
Department of Gastroenterology, Chongqing Hechuan District People’s Hospital
School of Medicine, Chongqing University
Chongqing Key Laboratory of Precision Prevention and Treatment for Digestive System Tumors, Department of Gastroenterology, Army Medical Center of PLA/Daping Hospital of Third Military Medical University
Department of Hematology, the First Hospital of Lanzhou University